⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVNO News
enVVeno Medical Corporation Common Stock
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
accessnewswire.com
NVNO
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
accessnewswire.com
NVNO
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
accessnewswire.com
NVNO
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
accessnewswire.com
NVNO
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
accessnewswire.com
NVNO
Form 8-K
sec.gov
NVNO
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
accessnewswire.com
NVNO
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
accessnewswire.com
NVNO
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
accessnewswire.com
NVNO
enVVeno Medical Announces Reverse Stock Split
accessnewswire.com
NVNO